Proangiogenic Interactions of Vascular Endothelial MMP14 With VEGF Receptor 1 in VEGFA-Mediated Corneal Angiogenesis

Kyu-Yeon Han1, Jin-Hong Chang1, Hyun Lee2

  • 1Department of Ophthalmology and Visual Sciences Illinois Eye and Ear Infirmary, College of Medicine, University of Illinois at Chicago, Chicago, Illinois, United States.

Abstract

Insights

Matrix metalloproteinase 14 (MMP14) is crucial for corneal angiogenesis by selectively cleaving vascular endothelial growth factor receptor 1 (VEGFR1). This interaction is essential for VEGFA-induced blood vessel growth.

Area of Science:

  • Molecular Biology
  • Angiogenesis Research
  • Biochemistry

Background:

  • Matrix metalloproteinase 14 (MMP14) is recognized for its role in corneal angiogenesis.
  • The precise mechanism of MMP14's proangiogenic activity remains under investigation.

Purpose of the Study:

  • To investigate the hypothesis that MMP14's proangiogenic activity stems from its selective binding and cleavage of vascular endothelial growth factor receptor 1 (VEGFR1).
  • To differentiate MMP14's interaction with VEGFR1 from its interaction with VEGFR2 and VEGFR3.

Main Methods:

  • Incubation of recombinant human VEGFR1, VEGFR2, and VEGFR3 with MMP14, followed by SDS-PAGE and Coomassie blue staining.
  • Surface plasmon resonance to quantify binding affinities (KD) between MMP14 and VEGFA/VEGFRs.
  • Assays for ERK phosphorylation in vascular endothelial cells and ex vivo/in vivo angiogenesis models (aortic ring and corneal neovascularization assays) in genetically modified mice.

Main Results:

  • MMP14 enhanced VEGFA-induced ERK phosphorylation in vascular endothelial cells in a dose- and time-dependent manner.
  • Conditional deletion of vascular MMP14 in mice led to diminished VEGFA-induced vessel sprouting in aortic ring assays and reduced corneal angiogenesis in vivo.
  • VEGF-induced angiogenesis was impaired, while basic fibroblast growth factor-induced angiogenesis was unaffected.

Conclusions:

  • VEGFR1 interaction with MMP14 and MMP14's enzymatic activity are essential for VEGFA-induced angiogenesis.
  • Selective cleavage of VEGFR1 by MMP14 appears to be a key mechanism in VEGFA-driven corneal angiogenesis.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.9K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
7.5K
Overview of Cell-Matrix Interactions01:24

Overview of Cell-Matrix Interactions

The extracellular matrix or ECM holds cells together to form a tissue and allows the cells within the tissue to communicate. ECM comprises proteins such as fibronectin, collagen, laminin, etc. The most abundant protein in this space is collagen. Collagen fibers are interwoven with carbohydrate-containing protein molecules called proteoglycans. ECM allows cell migration and provides a structural scaffold at cell adhesion that anchors the cell when the extracellular matrix proteins interact with...
9.6K